1-20 of 27
Authors: Walter J Storkus
Journal Article
Antagonism of regulatory ISGs enhances the anti-melanoma efficacy of STING agonists Get access
The Journal of Immunology, Volume 210, Issue Supplement_1, May 2023, Page 89.17, https://doi.org/10.4049/jimmunol.210.Supp.89.17
Published: 01 May 2023
Journal Article
STING agonism combined with arginase and PTGES/COX2 inhibitors for improved anti-tumor immunotherapeutic benefit Get access
The Journal of Immunology, Volume 206, Issue 1_Supplement, May 2021, Page 67.07, https://doi.org/10.4049/jimmunol.206.Supp.67.07
Published: 01 May 2021
Journal Article
PD1 Blockade of Tumor-primed CD4 T Cells Instigates Protective Immunity Against Tumor Rechallenge Get access
The Journal of Immunology, Volume 206, Issue 1_Supplement, May 2021, Page 57.25, https://doi.org/10.4049/jimmunol.206.Supp.57.25
Published: 01 May 2021
Journal Article
Therapeutic Induction of Tertiary Lymphoid Structures in Melanoma using STING Agonists Get access
The Journal of Immunology, Volume 202, Issue 1_Supplement, May 2019, Page 194.27, https://doi.org/10.4049/jimmunol.202.Supp.194.27
Published: 01 May 2019
Journal Article
IL-36γ promotes a local immune response via the formation of tertiary lymphoid structures in colorectal carcinoma. Get access
The Journal of Immunology, Volume 200, Issue Supplement_1, May 2018, Page 178.21, https://doi.org/10.4049/jimmunol.200.Supp.178.21
Published: 01 May 2018
Journal Article
Modulation of tumor vasculature promotes tertiary lymphoid organogenesis. Get access
The Journal of Immunology, Volume 196, Issue 1_Supplement, May 2016, Page 213.11, https://doi.org/10.4049/jimmunol.196.Supp.213.11
Published: 01 May 2016
Journal Article
Genetic Vaccines To Potentiate the Effective CD103+ Dendritic Cell–Mediated Cross-Priming of Antitumor Immunity Get access
The Journal of Immunology, Volume 194, Issue 12, June 2015, Pages 5937–5947, https://doi.org/10.4049/jimmunol.1500089
Published: 15 June 2015
Journal Article
Tumor-Derived Vascular Pericytes Anergize Th Cells Get access
The Journal of Immunology, Volume 191, Issue 2, July 2013, Pages 971–981, https://doi.org/10.4049/jimmunol.1300280
Published: 15 July 2013
Journal Article
Vaccines Targeting Tumor Blood Vessel Antigens Promote CD8+ T Cell-Dependent Tumor Eradication or Dormancy in HLA-A2 Transgenic Mice Get access
The Journal of Immunology, Volume 188, Issue 4, February 2012, Pages 1782–1788, https://doi.org/10.4049/jimmunol.1101644
Published: 15 February 2012
Journal Article
Intralesional Delivery of Dendritic Cells Engineered to Express T-bet Promotes Protective Type 1 Immunity and the Normalization of the Tumor Microenvironment Get access
The Journal of Immunology, Volume 185, Issue 5, September 2010, Pages 2895–2902, https://doi.org/10.4049/jimmunol.1001294
Published: 01 September 2010
Journal Article
Ectopic T-bet Expression Licenses Dendritic Cells for IL-12-Independent Priming of Type 1 T Cells In Vitro Get access
The Journal of Immunology, Volume 183, Issue 11, December 2009, Pages 7250–7258, https://doi.org/10.4049/jimmunol.0901477
Published: 01 December 2009
Journal Article
Tumor-Derived Microvesicles Promote Regulatory T Cell Expansion and Induce Apoptosis in Tumor-Reactive Activated CD8+ T Lymphocytes Get access
The Journal of Immunology, Volume 183, Issue 6, September 2009, Pages 3720–3730, https://doi.org/10.4049/jimmunol.0900970
Published: 15 September 2009
Journal Article
Enhancement in Specific CD8+ T Cell Recognition of EphA2+ Tumors In Vitro and In Vivo after Treatment with Ligand Agonists Get access
The Journal of Immunology, Volume 181, Issue 11, December 2008, Pages 7721–7727, https://doi.org/10.4049/jimmunol.181.11.7721
Published: 01 December 2008
Journal Article
Stat6 Signaling Suppresses VLA-4 Expression by CD8+ T Cells and Limits Their Ability to Infiltrate Tumor Lesions In Vivo Get access
The Journal of Immunology, Volume 181, Issue 1, July 2008, Pages 104–108, https://doi.org/10.4049/jimmunol.181.1.104
Published: 01 July 2008
Journal Article
Conditional triggering of EphA2 epitope presentation results in the enhanced tumor cell recognition by specific CTL. (48.25) Get access
The Journal of Immunology, Volume 178, Issue 1_Supplement, April 2007, Page S79, https://doi.org/10.4049/jimmunol.178.Supp.48.25
Published: 01 April 2007
Journal Article
RTK-based vaccines elicit specific CD8+ T cell responses in HLA-A2 transgenic mice (48.1) Get access
The Journal of Immunology, Volume 178, Issue 1_Supplement, April 2007, Page S74, https://doi.org/10.4049/jimmunol.178.Supp.48.1
Published: 01 April 2007
Journal Article
Treatment-Enhanced CD4+Foxp3+ Glucocorticoid-Induced TNF Receptor Family RelatedHigh Regulatory Tumor-Infiltrating T Cells Limit the Effectiveness of Cytokine-Based Immunotherapy Get access
The Journal of Immunology, Volume 178, Issue 6, March 2007, Pages 3400–3408, https://doi.org/10.4049/jimmunol.178.6.3400
Published: 15 March 2007
Journal Article
Delivery of Dendritic Cells Engineered to Secrete IFN-α into Central Nervous System Tumors Enhances the Efficacy of Peripheral Tumor Cell Vaccines: Dependence on Apoptotic Pathways Get access
The Journal of Immunology, Volume 175, Issue 4, August 2005, Pages 2730–2740, https://doi.org/10.4049/jimmunol.175.4.2730
Published: 15 August 2005
Journal Article
IL-4-Transfected Tumor Cell Vaccines Activate Tumor-Infiltrating Dendritic Cells and Promote Type-1 Immunity Get access
The Journal of Immunology, Volume 174, Issue 11, June 2005, Pages 7194–7201, https://doi.org/10.4049/jimmunol.174.11.7194
Published: 01 June 2005
Journal Article
Dendritic Cells Mediate NK Cell Help for Th1 and CTL Responses: Two-Signal Requirement for the Induction of NK Cell Helper Function Get access
The Journal of Immunology, Volume 171, Issue 5, September 2003, Pages 2366–2373, https://doi.org/10.4049/jimmunol.171.5.2366
Published: 01 September 2003
